RegMed Daily Dialogue, Mid-Day, 9/14/11, pessimism deepens as confidence falls further
The 6 W’s: Who, what, where, when, why and what of it… Read more…
The 6 W’s: Who, what, where, when, why and what of it… Read more…
Good morning! Read more…
End of Day, Cause and Effect, so what’s causing the rise or bounces? Read more…
The 6 W’s: Who, what, where, when, why and what of it… Read more…
KOOL reported a Q4/11 net loss of $1.2M or $0.07 per share Read more…
Good morning! Here’s what you might need to know to start the day… to understand the gyrations in the RegMed universe’s market!
End of Day, Cause and Effect, so what’s causing the rise or bounces? Read more…
The 6 W’s: Who, what, where, when, why and what of it… Read more…
ASX: ACL is about to initiate recruitment to a 390 patient pivotal P3 study of HA-Irinotecan in metastatic colorectal (bowel) cancer. Read more…
Starting the day followed by early news and Rodman & Renshaw conference presentations. Read more…

Founder and Director of Research, Henry McCusker enters his eighth (8) year at Scimitar Equity with past experience in sell-side analysis, buy-side management, corporate management and due diligence.
I started this blog to add commentary, update news flow and insightful opinions that are intelligent, fit to print and SEC compliant.